Similar to RA, dysregulated IL-1-mediated events also impinge on the development of osteoarthritis; however, therapeutic targeting of IL-1 has only provided modest improvements in clinical trials (Chevalier et al., 2009). This evidence concerns the gene IL1B and osteoarthritis.